3.93
price up icon10.08%   0.36
after-market Handel nachbörslich: 4.07 0.14 +3.56%
loading

Cytomx Therapeutics Inc Aktie (CTMX) Neueste Nachrichten

pulisher
08:46 AM

What insider purchases suggest about CytomX Therapeutics Inc. (6C1) stockGlobal Markets & Reliable Intraday Trade Plans - newser.com

08:46 AM
pulisher
07:38 AM

Will CytomX Therapeutics Inc. (6C1) stock outperform Dow Jones2025 Historical Comparison & Growth Focused Investment Plans - newser.com

07:38 AM
pulisher
07:22 AM

Visual analytics tools that track CytomX Therapeutics Inc. performanceJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com

07:22 AM
pulisher
06:25 AM

Why CytomX Therapeutics Inc. (6C1) stock is a strong buy call2025 Trading Recap & Fast Gaining Stock Strategy Reports - newser.com

06:25 AM
pulisher
04:33 AM

How to integrate CytomX Therapeutics Inc. into portfolio analysis toolsJuly 2025 Review & Weekly Watchlist for Consistent Profits - newser.com

04:33 AM
pulisher
02:16 AM

Will CytomX Therapeutics Inc. stock reach Wall Street targetsJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com

02:16 AM
pulisher
02:13 AM

What analyst consensus implies for CytomX Therapeutics Inc. (6C1) stockJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com

02:13 AM
pulisher
12:53 PM

Is CytomX Therapeutics Inc. (6C1) stock a buy on weakness2025 Biggest Moves & Stock Portfolio Risk Control - newser.com

12:53 PM
pulisher
Nov 02, 2025

Why retail traders accumulate CytomX Therapeutics Inc. (6C1) stockAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using data filters to optimize entry into CytomX Therapeutics Inc.Market Trend Report & Reliable Intraday Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How CytomX Therapeutics Inc. stock performs in rate cut cyclesJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What dividend safety rating applies to CytomX Therapeutics Inc. (6C1) stockBond Market & AI Forecasted Entry and Exit Points - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 12:38:04 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Key metrics from CytomX Therapeutics Inc.’s quarterly data2025 Earnings Surprises & Technical Buy Zone Confirmations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What earnings margins imply for CytomX Therapeutics Inc. (6C1) stockJuly 2025 Intraday Action & Daily Volume Surge Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using Ichimoku Cloud for CytomX Therapeutics Inc. technicalsQuarterly Portfolio Report & Long-Term Capital Growth Strategies - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How CytomX Therapeutics Inc. stock reacts to oil pricesJuly 2025 Short Interest & Weekly Return Optimization Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Why analysts maintain buy rating on CytomX Therapeutics Inc. (6C1) stockShort Setup & Real-Time Volume Triggers - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What drives CytomX Therapeutics Inc 6C1 stock priceMarket Sentiment Report & Trusted Financial Advisors at No Cost - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Is CytomX Therapeutics Inc. (6C1) stock considered safe havenTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Building trade automation scripts for CytomX Therapeutics Inc.2025 Macro Impact & AI Driven Stock Movement Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can CytomX Therapeutics Inc. stock reach $100 price targetJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How CytomX Therapeutics Inc. stock compares to market leadersJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Oppenheimer Remains a Buy on CytomX Therapeutics (CTMX), Sets a $7 PT - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

CytomX Therapeutics, Inc. to Report Third Quarter Financial Results on November 6, 2025 - Quiver Quantitative

Oct 30, 2025
pulisher
Oct 30, 2025

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 05:08:21 - newser.com

Oct 30, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):